Cardiometabolic Complications of Obesity
Obesity is a major risk factor for cardiometabolic diseases including hypertension, dyslipidemia, atherosclerosis, and heart failure. Excess adiposity induces endothelial dysfunction, vascular inflammation, and altered lipid metabolism, accelerating cardiovascular morbidity and mortality. Insulin resistance and metabolic syndrome further amplify cardiovascular risk. Preventive strategies targeting weight reduction, blood pressure control, and lipid optimization are essential. Advances in imaging, biomarkers, and therapeutic approaches are enabling earlier detection and intervention, ultimately reducing the burden of obesity-associated cardiovascular disease globally.